Ftse Mib
33.778,74
-1,51%
DAX
17.932,17
-1,10%
S&P 500
5.035,69
-1,57%
NASDAQ Composite
15.657,82
-2,04%
Bitcoin
60.368,39
-5,43%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Royalty Pharma PLC (RPRX) Royalty Pharma PLC (RPRX) Notizie

Royalty Pharma PLC

RPRX
27,70
-0,42 (-1,49%)
Dopo l'orario di negoziazione
Ultimo aggiornamento: 22:00:17
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
19/4/202414:15GLOBERoyalty Pharma to Announce First Quarter 2024 Financial..
17/4/202414:15GLOBERoyalty Pharma Declares Second Quarter 2024 Dividend
28/2/202422:15GLOBERoyalty Pharma to Present at TD Cowen’s 44th Annual Health..
15/2/202415:05EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
15/2/202413:33EDGAR2Form 8-K - Current report
15/2/202413:30GLOBERoyalty Pharma Reports Q4 and Full Year 2023 Results
06/2/202413:01EDGAR2Form 8-K - Current report
30/1/202422:15GLOBERoyalty Pharma To Announce Fourth Quarter And Full Year 2023..
19/1/202414:15GLOBERoyalty Pharma Announces Dividend Increase
08/1/202413:18EDGAR2Form 8-K - Current report
08/1/202413:00GLOBERoyalty Pharma Highlights Accomplishments and Provides..
03/1/202422:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202422:30EDGAR2Form 144 - Report of proposed sale of securities
29/12/202322:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/12/202322:31EDGAR2Form 8-K - Current report
27/12/202319:05EDGAR2Form 8-K - Current report
19/12/202322:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/12/202322:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/12/202322:47EDGAR2Form 144 - Report of proposed sale of securities
27/11/202322:15GLOBERoyalty Pharma to Present at the Evercore ISI 6th Annual..
16/11/202323:16EDGAR2Form 8-K - Current report
16/11/202323:13EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
15/11/202301:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/11/202314:10GLOBERoyalty Pharma and Teva Collaborate to Further Accelerate..
13/11/202314:00BWTeva and Royalty Pharma Collaborate to Further Accelerate..
08/11/202315:04EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/11/202313:40EDGAR2Form 8-K - Current report
08/11/202313:00GLOBERoyalty Pharma Reports Third Quarter 2023 Results
19/10/202315:29EDGAR2Form 8-K - Current report
19/10/202313:59GLOBERoyalty Pharma Announces Agreement to Purchase Up to $1.5..
16/10/202322:15GLOBERoyalty Pharma Declares Fourth Quarter 2023 Dividend
11/10/202322:15GLOBERoyalty Pharma To Announce Third Quarter 2023 Financial..
03/10/202322:15EDGAR2Form 144 - Report of proposed sale of securities
03/10/202322:15EDGAR2Form 144 - Report of proposed sale of securities
21/9/202314:25GLOBERoyalty Pharma Appoints Eric Schneider as Chief Technology..
05/9/202322:15GLOBERoyalty Pharma and Ascendis Pharma Enter Into $150 Million..
05/9/202322:01GLOBEAscendis Pharma and Royalty Pharma Enter into $150 Million..
05/9/202314:25GLOBERoyalty Pharma to Present at Upcoming Investor Conferences
24/8/202312:30GLOBERoyalty Pharma and Ferring Pharmaceuticals Enter Into US..
24/8/202307:15BWRoyalty Pharma and Ferring Pharmaceuticals Enter into US..
11/8/202323:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/8/202322:45EDGAR2Form 144 - Report of proposed sale of securities
08/8/202323:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/8/202323:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/8/202315:03EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/8/202313:31EDGAR2Form 8-K - Current report
08/8/202313:00GLOBERoyalty Pharma Reports Second Quarter 2023 Results
18/7/202322:15GLOBERoyalty Pharma to Announce Second Quarter 2023 Financial..
17/7/202322:15GLOBERoyalty Pharma Declares Third Quarter 2023 Dividend
15/7/202300:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
Apertura: 28,05 Min: 27,68 Max: 28,13
Chiusura: 28,12

La tua Cronologia

NASDAQ
RPRX
Royalty Pharma
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network